In this study we describe alternative splicing of somatically mutated immunoglobulin (Ig) variable heavy chain (V H ) genes in three distinct primary B cell non-Hodgkin's lymphomas (B-NHL). In two V4-34 expressing lymphomas, ie a post-germinal center type B cell chronic lymphocytic leukemia (B-CLL) and a follicular lymphoma (FL), internally spliced V H gene transcripts were found in which a sequence stretch of 116 bp between the framework region 1 (FR1) and complementarity determining region 2 (CDR2) had been deleted. We provide evidence that for this alternative IgV H mRNA processing a known cryptic 5Ј splice donor site and a previously unidentified cryptic 3Ј splice acceptor site were used. Site-directed mutagenesis showed that the cryptic 3Ј splice acceptor site had been activated by specific somatic point mutations. The B-CLL further harbored a triplication of the rearranged JH3 gene segment including the putative N region and part of the JH3-JH4 intron sequence. This triplication probably took place via a repeated mechanism of DNA double strand break followed by homologous recombination, a mechanism which was recently proposed also involved in the somatic hypermutation process and is compatible with the post-germinal center derivation of this B-CLL. Finally, in a V4-34 expressing diffuse large B cell lymphoma, we observed alternative IgV H mRNA processing using the same cryptic 5Ј splice donor site and the normal splice acceptor site of the CH1-C exon. The significance of alternative IgV H processing in B cell malignancies and as a potential mechanism of somatic Ig diversification is discussed. Leukemia (2002) 16, 636-644.
Introduction
During early B cell development in the bone marrow, IgV regions of both heavy (H) and light (L) chain genes are formed by recombination of V, (D) and J gene segments. The potential recombinatorial repertoire, that includes the 'random' pairing of IgH and IgL chains, is significantly enlarged due to imprecise joining of the different gene segments. This junctional diversity depends largely on the enzyme terminal deoxynucleotidyl transferase (TdT), that is responsible for the addition of non-templated so called N-nucleotides to the V(D)J junctions. 1, 2 In mature B cells, the IgV regions can be further diversified, particularly in the course of T helper cell-dependent antigen-specific responses in germinal centers (GC). Here, the Ig loci may be altered by somatic hypermutation and IgH chain class-switch recombination. It has recently been reported that the somatic hypermutation process, that is believed to occur in the GC environment exclusively, [3] [4] [5] [6] not only involves single nucleotide exchanges but also, to a significant extent, deletions and insertions of different size. 7, 8 Furthermore, as the RAG genes may be expressed during the GC stage, it has been proposed that secondary Ig rearrange- ments may rescue GC B cells with unfavorable somatic mutations, a process also designated as receptor revision. Indeed, in both mice and humans recombination intermediates have been detected in GC B cells. [9] [10] [11] Although most examples of receptor revision involved IgV L genes, it has also recently been demonstrated in human IgV H genes. 12, 13 It is currently believed that, due to the occurrence of these complex genetic alterations, the GC reaction plays a role in lymphomagenesis. This notion is supported by the fact that the majority of non-precursor B-NHL entities express somatically mutated V genes, compatible with a GC or post-GC derivation. 14 In follicular lymphoma (FL), the cytological and architectural characteristics as well as the immunophenotype are all highly compatible with a GC derivation. 15, 16 B-CLL was initially considered to be derived from naive B cells. 17, 18 However, Fais et al 19 recently reported that, within a large panel of B-CLL, approximately 50% of the IgM + B-CLL and 75% of the non-IgM + B-CLL cells exhibit somatic mutations in their IgV H genes. Moreover, similar to normal (post) GC B cells 20, 21 and (post) GC-derived B cell malignancies, 22, 23 the BCL-6 gene was found to be somatically mutated in a fraction of the IgV H mutated B-CLLs. 24 These data also indicate that a substantial proportion of B-CLL derive from GC-experienced B cells. Furthermore, these findings suggest that within the clinicopathological group of B-CLL, at least two separate entities are included. In accordance, two recent studies indicated that patients with somatically mutated B-CLL IgV genes have a significantly better prognosis than those with unmutated IgV genes. 25, 26 Here, we present IgV H gene analyses of three distinct GCderived B cell malignancies in which we observed alternative processing of the rearranged and somatically mutated V4-34 IgV H gene segment. We provide evidence that the internal IgV H mRNA splicing observed in a B-CLL and in a FL was not due to a defect in the splicing machinery of the tumor cells but caused by specific somatic nucleotide substitutions which activated a previously unidentified cryptic 3Ј splice acceptor site present in some germline IgV H gene segments.
Materials and methods

Patient material
One patient was a 76-year-old female who suffered from B-CLL accompanied by severe auto-immune hemolytic anemia (AIHA), for which she was splenectomized. Fresh frozen spleen tissue was obtained from the Department of Pathology, the Westeinde Hospital, The Hague, The Netherlands. The second patient (FL13) was a 78-year-old male who suffered from lymphadenopathy; a supraclavicular lymph node was removed on which a follicular lymphoma was diagnosed. 27 The third patient (DLBCL4) was a 77-year-old female who suffered from diffuse large B cell lymphoma which was diag-nosed on a groin lymph node. The second and the third patient were from our hospital.
DNA, RNA isolation and cDNA synthesis
DNA and RNA was isolated using the DNAZOL or the TRI-ZOL reagent, respectively (Life Technologies, Breda, The Netherlands) according to the manufacturer's instructions. cDNA was synthesized with Pd(N) 6 random primers (Pharmacia Biotech, Roosendaal, The Netherlands) or for some experiments with an oligo-dT primer (Promega, Leiden, The Netherlands) as described. 27, 28 
PCR reactions
The complementary determining region 3 (CDR3) was amplified using a forward primer specific for the framework region 3 (FR3) in combination with one of the different downstream primers specific for JH, C, C␥, C␣ or C␦. For the VH familyspecific PCR, the reactions were performed with VH familyspecific leader primers combined with the appropriate reverse primer, either JH, C, C␦ or the B-CLL specific FR3 reverse primer. The different PCRs were performed with 1 l of cDNA or 500 ng genomic DNA in a volume of 25 l. Primer sequences were as described; 27, 28 B-CLL FR3 5Ј-CGGCGGTCACAGAGCCTCAA-3Ј
Cloning and sequencing PCR products were cloned into pTOPO vectors and transformed into TOP10 bacteria, according to the manufacturer's instructions (Invitrogen, Groningen, The Netherlands). The colonies were sequenced on both strands. Sequencing was performed with an ABI sequencer (Perkin Elmer Corporation, Norwalk, CT, USA) using the big dye-terminator cyclesequencing kit. The sequences found were compared to published germline sequences, using the Vbase database 29, 30 and DNAplot 31 on Internet (http://www.mrc-cpe.cam.ac.uk) to identify mutations.
Expression vectors
The IgH(␥3) expression vector was produced by modifying the pRTM1 vector. 32 The IgH expression vector consists of a rearranged V(D)J gene flanked by ClaI and SpeI restriction sites, which are used to introduce the IgV H gene of interest. Downstream, the C␥3 constant gene is located. The expression of the recombinant IgH is regulated by normal human IgH promotor and enhancer sequences. For selection in mammalian cells the neomycin phosphotransferase gene is present, which allows selection of stably transfected cells with geneticin. The IgL() expression vector was produced starting from the pSVG-V3 vector. 32 The IgL() expression vector consists of a rearranged VJ gene flanked by ClaI and NotI restriction sites. These restriction sites are used to introduce the IgV gene of interest. The constant gene is located downstream. The expression of the recombinant Ig is regulated by normal human Ig promotor and enhancer sequences. Detailed description of the generation of these immunoglobulin expression vectors is available on request.
The pRTM1 and the pSVG-V3 vectors were kindly pro- 
Generation of transfectants in SP2/0 cells
For transfection, 10 g IgH(␥3) and 10 g IgL() were linearized with PvuI and mixed with 10 × 10 6 SP2/0 myeloma cells in Iscove's modified Dulbecco's medium (IMDM) containing 10% FCS (Hyclone, Logan, UT, USA), 100 IU/ml penicillin and 100 g/ml streptomycin. The suspension was electroporated in a 0.4 cm gap cuvette using a Biorad gene pulser with capacity extender at 960 F and 250 V. The cells were selected and cultured in IMDM complete medium containing 400 g/ml geneticin (Life Technologies).
Nucleotide reversion of the somatic mutation in codon 64 of the B-CLL
Primers were designed that matched around codon 64, one primer included one mismatch which reversed the somatic mutation in codon 64 to the germline nucleotide. The V4-34 of the B-CLL was amplified in two separate parts: the 5Ј part with the VH4 family-specific primer in combination with B-CLL-R containing the mismatch that reversed the somatic mutation; the 3Ј part was amplified with the B-CLL-F primer combined with the JH primer. These PCRs were performed according to the protocol used for the VH family-specific PCR except that Pfu polymerase was used (Stratagene, La Jolla, CA, USA). The two parts were purified, combined and used as template in a VH4-specific PCR. Bacterial clones were generated and sequenced to confirm the reversion of the somatic mutation in codon 64. Next, this B-CLL V4-34 fragment was cloned into the IgH(␥3) expression vector as described above. Primer sequences were as follows: B-CLL-F 5Ј-GAGTCACCA-TATCAGTGGAC-3Ј ; B-CLL-R 5Ј-GACTCTTGAGGGACGGG TTG-3Ј. The underlined nucleotide is a mismatch which reverts the somatic mutation in codon 64.
Results
Assessment of clonality, IgH chain isotype expression and V H and V L gene family usage of the B-CLL
Clonality of the B-CLL was demonstrated immunohistochemically and confirmed by Southern blot, using a JH probe (data not shown) 33 as well as by a CDR3-specific PCR. This PCR makes use of clone-dependent length differences of the CDR3 regions in the V H chains. A CDR3-PCR of a polyclonal B cell population yields products of variable size, visible as multiple bands or a smear pattern on agarose gel, whereas a clonal B cell population yields a single band. The CDR3 region of the rearranged immunoglobulin IGH locus was amplified from both genomic DNA and complementary DNA (cDNA), using a combination of the FR3 and the JH primer. To determine the constant IgH chain (CH) isotype of the B-CLL, cDNA was also amplified using the FR3 primer in combination with different CH-specific primers (C, C␦, C␥ and C␣). Unexpectedly, with the FR3-JH primer combination, from both cDNA and genomic DNA three clonal products of 112 bp, 184 bp and 297 bp were amplified (Figure 1b) . With FR3-CH primer combinations, a sharp band was only observed with the C and C␦ primers, which was in accordance with the immunohistochemically demonstrated co-expression of IgM and IgD. With both the C␥ and C␣ primers, a smear pattern was obtained, most likely derived from polyclonal non-neoplastic B cells and/or plasma cells. Formally, however, the presence of a minor subpopulation of class-switched tumor cells cannot be ruled out ( Figure 1b ). Subsequently, the IgV genes were amplified with family-specific V H or V leader primers in combination with the JH, C and C␦ or J and C downstream primers, respectively. On genomic DNA, only JH or J downstream primers were used in view of the presence of JH-CH and J-C intronic sequences. The V H family-specific PCRs revealed that the B-CLL expressed a VH4 family gene segment (data not shown). The PCR on genomic DNA with the VH4 leader primer in combination with the JH primer yielded three clear products of 516, 588 and 701 bp, respectively, and a larger, albeit weaker product of 1071 bp (Figure 1c) . The same PCR on cDNA also resulted in at least three clear bands. With the C downstream primer, a 473 bp product and a weaker 357 bp product were visible, whereas with the C␦ primer only one product was detectable (Figure 1c) . The general length difference between the IgV H family PCR products generated from either genomic DNA or cDNA is explained by the 83 bp leader intron present in genomic DNA only.
By V family-specific PCR and sequencing, it was determined that the B-CLL expresses a V1 family gene segment (data not shown).
The IGH-chain locus of the B-CLL
To clarify the structure of the IGH locus of the B-CLL, the product obtained by the VH4-family specific PCR on genomic DNA was cloned. By CDR3 PCR, we identified clones with CDR3 products of 112, 184 and 297 bp, thus identical to the products found in the CDR3 PCR on genomic DNA ( Figure  1b) . One of the plasmid clones contained an extra long 667 bp CDR3 product. A VH4 family-specific PCR on this particular bacterial clone yielded a 1071 bp product, comparable to the largest product obtained in the VH4 family-specific PCR on total genomic DNA ( Figure 1c) . Clones, representative of the four different CDR3 lengths found, were sequenced. The V H region of the B-CLL displayed highest homology with the V4-34, D4 and JH3b germline gene segments, respectively (Figure 2) . 29, 34 In the V H gene segment, a total of 13 somatic mutations were identified. The CDR1 and CDR2 carried five somatic mutations with a replacement vs silent (R/S) mutation ratio of 1.5. The FRs contained eight somatic mutations with an R/S ratio of 0.3.
Interestingly, we found that the IGH locus of the B-CLL contained a triplication of the JH3b gene segment. The second JH3b (JH3b-II) gene segment was located 21 bp downstream of JH3b-I, in the JH3-JH4 intron and the third JH3b gene segment (JH3b-III) was located 55 bp downstream of JH3b-II, again in the JH3-JH4 intron. The somatic mutations in the three successive JH3b gene segments, with parts of the JH3-JH4 intronic sequence, were all unique except for one mutation that was shared by the JH3b-I and JH3b-III gene segment ( Figure 2) .
Since in each of the three JH3b copies the 5Ј splice donor site was preserved, potentially VH4 transcripts can be produced coupling one, two or three JH3b copies to CH gene segments. To investigate whether this was the case, bacterial clones were produced from the VH4 RT-PCR products obtained with the JH, C and C␦ downstream primers, respectively. Nested CDR3-PCR on these cloned VH4 RT-PCR products, using the JH downstream primer, again yielded products with one, two or three JH3b copies, of 112, 184 and 297 bp, respectively. However, the clones derived from VH4 PCR products generated with the CH1-C and CH1-C␦ downstream primers contained the short CDR3 length of 112 bp only. Also, when a CH3-C downstream primer was used, Leukemia only amplimers with one JH3b segment were found (data not shown), excluding the possibility that the two-and/or threeJH3b containing transcripts had been spliced to the second or third C exon (CH2, CH3). It thus seems that the majority of and ␦ transcripts contain a functional IgV H region with a single JH3b segment. Moreover, it is noteworthy that from the putative RNA message containing all three JH3b gene segments, no protein product is to be expected due to a frameshift directly upstream of the third JH3b gene segment. A total of 20 cDNA-derived PCR clones of the different lengths were sequenced. We did not detect intraclonal point mutation differences between the cloned IgV sequences, which is in accordance with a previous study on B-CLL. 35 Also, the rearranged V1 gene harbored somatic point mutations (four in the CDRs and six in the FRs) compared to the most homologous germline V1 gene segment, DPK3/L11 (data not shown).
Alternative splicing of V4-34 gene transcripts
In addition to the described transcripts with differences in the number of JH3b copies included, we found in eight of the 20 cDNA-derived PCR clones of the B-CLL a 116 bp deletion (between codons 26 and 64) within the V4-34 gene segment (Table 1, Figures 2 and 3a) . Detailed analyses of the sequences flanking this deletion indicated that the 5Ј site at codon 26 (FR1) was strongly homologous with the mammalian 5Ј splice site consensus sequence (5Ј A/C A G ↓ GT
Figure 3
Comparison of the V4-34 expressed by the B-CLL (a) and FL13 (b) with 5Ј and 3Ј consensus splice sites. FR1, frame work region 1; CDR2 complementarity determining region; ͉ nucleotide matching the consensus sequence; x, nucleotide not matching the consensus sequence; * mutation that resulted in a closer homology with the consensus splicing sequence; +, mutation not resulting in a closer homology with the splicing consensus sequence. The somatic mutations in codon 64, which resulted in closer homologies to the 3Ј splice acceptor site are marked by arrows. The underlined nucleotides are necessary for RNA splicing. M = A or C, R = A or G, N = any nucleotide and Y = T or C.
A/G A G T 3Ј) whereas the 3Ј site at codon 64 displayed homology for the 3Ј splice site consensus sequence (5Ј (Y) n N Y AG ↓ G 3Ј). 36 In these splice acceptor and donor sites the underlined nucleotides are highly conserved whereas the doubly underlined nucleotides are absolutely necessary for RNA splicing. Interestingly, a nucleotide substitution in codon 64 (A → C) had caused a closer homology to the consensus 3Ј splice acceptor site at a critical position. In addition, the mammalian branch-point consensus sequence, which maps 18-38 nucleotides upstream of the 3Ј splice site (5Ј T N C T R A C 3Ј), was present in the mutated V4-34 and here also a specific somatic mutation had contributed to a closer homology (Figure 3a) . 36 The clones with this deletion were all devoid of the VH4 leader intron, proving the RNA derivation of the cloned fragments. This, and the fact that we did not isolate genomic DNA-derived clones with the V4-34 deletion, indicates that this deletion was the result of alternative splicing. It must be noted that the alternative V4-34 splicing is accompanied by a shift of the reading frame and the putative messenger RNA thus cannot be translated. In Figure 4 , a summary is provided of the different transcripts found in the B-CLL. With the information obtained, the smaller band of 357 bp in the VH4-family specific PCR with the C primer ( Figure  1c ), is now explained as an alternatively spliced V4-34 gene.
Based on these findings we analyzed the IgV H transcripts of three previously studied IgM + , V4-34-expressing FLs, Nos 13, 15 and 67 27 and an IgM + , V4-34-expressing diffuse large B cell lymphoma (DLBCL4). Figure 5 shows that in a VH4-C RT-PCR, a small product of approximately 350 bp was not only present in the B-CLL but also in FL13. In contrast, in FLs Nos.15, 67 and in DLBCL4 this particular product was not detected. Instead, in DLBCL4 a 180 bp product was visible. FL13 co-expressed and ␦ IgH chains, harboring nine somatic mutations compared to the V4-34 germline in association with an IgL chain. 27 Surprisingly, in this case a nucleotide substitution in codon 64 (A → G) of V4-34 was found as well that, although at a position different from that in the B-CLL, also gave rise to a closer homology with the consensus 3Ј splice acceptor site (Figure 3b ). Sequencing confirmed that the 350 bp product had been generated by similar V4-34 splicing which again was accompanied by a frameshift. In the DLBCL4 expressed a V4-34 with 35 somatic mutations, as assessed by sequencing of three plasmid clones. In the CDR1 and CDR2, nine somatic mutations were present with a replacement vs silent (R/S) mutation ratio of 2.0. The FRs contained 26 somatic mutations with an R/S ratio of 1.0. The intraclonal variation, which is calculated as the mean number of nucleotide differences for each molecular clone compared to the consensus sequence was 6.3 nucleotides/clone, which is rather high according to previous studies on DLBCLs and FLs. 27, 37 The 180 bp product represented an alternatively processed IgH transcript in which the cryptic 5Ј splice donor site at codon 26 was directly spliced to the CH1-C exon. In this case, as in FL13, no somatic mutations were found in the cryptic 5Ј splice donor site. This mode of splicing yields an in-frame truncated heavy chain and has been described previously in two VH4-expressing Burkitt's lymphoma cell lines.
38,39
Internal V4-34 splicing depends on a single nucleotide substitution
To exclude that the alternative V4-34 RNA processing was due to an aberrant splicing machinery of tumor B cells, we transfected SP2/0 myeloma cells with the B-CLL IgH. The B-CLL-derived V4-34 genes with either one JH3b (1J) or two JH3b (2J) gene copies were introduced into the pIgH(␥3) expression vector. The insert was at the 3Ј end flanked by an intron, including the normal Ig enhancer and by C␥3 sequences, respectively. In a similar fashion, the patient's V gene was introduced into the pIgL() expression vector. The pIgH(␥3)-1J and pIgH(␥3)-2J were each co-transfected with pIgL() in SP2/0 myeloma cells. The transfectants were selected with geniticin. On cDNA derived from these transfectants, we performed VH4 family-specific PCRs with a C␥ downstream primer or, for a more accurate detection of the V4-34 splice variant, a B-CLL-specific downstream FR3 primer Leukemia (Figure 6a ). In the PCRs on the pIgH(␥3)-2J transfectant with the C␥ as downstream primer, three products were detectable, of which the largest 530 bp product possessed two JH3b gene segments directly coupled to the C␥3 sequence (Figure 6b , lane 1). This is thus different from the B-CLL, in which transcripts with two JH3b gene segments were not found in contiguity with C or C␦. The lower 458 bp product was derived from a normal V(D)J coupled to C␥3, whereas the smallest 342 bp product represented the V4-34 splice variant with one JH3b gene segment coupled to C␥3. Theoretical transcripts representing the V4-34 splice variant with two JH3b gene segments coupled to C␥3, with a predicted length of 414 bp, were not detected. In the PCR on the pIgH(␥3)-1J transfectant, we detected a dominant 458 bp product and a very weak product of 342 bp, representing the unspliced and spliced V H region coupled to C␥3, respectively (Figure 6b, lane 2) . With the B-CLL-specific FR3 downstream primer, the V4-34 splice variant was also detectable in the 2J and the 1J transfectants (Figure 6c, lanes 1 and 2) . Here, no difference is visible between products with one JH3b or with two JH3b gene segments since in this PCR the downstream primer anneals 5Ј of the JH region. It is remarkable that in the 2J transfectant, the ratio of spliced:unspliced transcripts is significantly higher than in the 1J transfectant. This suggests that the abnormal size and structure of V H D-2J favors the use of the cryptic splice sites in V4-34.
As we suspected that the A → C mutation in codon 64 was pivotal by causing a closer homology to the consensus 3Ј splice acceptor site (Figure 3a) , we also transfected cells with 1J and 2J constructs in which this mutation had been reversed. By RT-PCR, we indeed found that in neither the 1J nor the 2J revertants were alternatively spliced V4-34 forms detectable (Figure 6b and c, lanes 3 and 4) . We therefore conclude that the alternative processing of V4-34 RNA is not invoked by a disturbed splicing machinery of the B-CLL but is V4-34-encoded and critically depends on one single point mutation.
Comparison of germline V H family genes with the consensus splice site sequences
Alignment analyses indicated that several of the germline V H genes bear, in the regions mentioned above, homology with the 5Ј and 3Ј splice consensus sequences. Although the extent of homology is variable among the different V H genes it is likely that, due to superimposed nucleotide substitutions, internal V H mRNA splicing is not confined to a single V H species. Of all V H family genes (codons 25-28), however, the germline sequences of the VH4 family members display the highest degree of homology with the consensus 5Ј splice site sequence. Except for the VH4 family genes and the V1-18 germline gene, none of the other germline V H genes contain the essential GT in codon 26 ( Figure 7 and data not shown). In addition, only V4-34 harbors the highly conserved guanine at the third position of codon 27 ( Figure 7) . Comparison of codons 56-65 of the V H family germline genes with the consensus 3Ј splice site sequence indicated that, although only the VH1 family members contain the essential YAG at codon 64, the overall homology was again most obvious for the VH4 family gene segments (Figure 7) . Although the V1-18 gene, in germline configuration, also potentially fulfills the requirements for the internal splicing we were unable to detect this phenomenon in two V1-18 expressing B cell lymphomas (data not shown). 
Discussion
In this report, we describe three B-NHLs of different types in which, apart from normal IgH gene transcripts, aberrant transcripts were detected due to an extraordinary make-up of the IGH chain locus and/or alternative processing of IgH mRNA.
The IGH locus of a B-CLL contained a triplication of the JH3b gene segment, which included parts of the JH3-JH4 intron sequence. Directly upstream of the JH3b-II and the JH3b-III segment, stretches of 5 bp and 13 bp respectively were present, each of which contained 4 bp homologous to putative N nucleotides directly upstream of the first JH3b segment (Figure 2b ). This suggests that the JH3b triplication took place in an already rearranged IGH locus. Moreover, this Nregion may have served as the target region in the triplication process that most likely took place in replicating cells, possibly via a repeated mechanism of DNA double strand break followed by homologous recombination. These alterations may have occurred in dividing precursors in the bone marrow after the initial IGH rearrangement had been completed. Alternatively, the finding that this B-CLL exhibited somatically mutated IgV genes, indicates that the neoplastic cells were derived from a (post) GC B cell, as has been described for approximately 50% of IgM-expressing B-CLLs. 19 As the somatic hypermutation process involves DNA double strand breaks possibly followed by repair via homologous recombination, 40 the triplication could also have occurred during the hypermutation process. An important argument that duplications occur during the GC reaction is the finding of both unique as well as shared point mutations in duplicated regions. 7, 8 In this B-CLL we found one mutation shared by the JH3b-I and JH3b-III segments. Assuming that the JH3b-I segment served as a template, it is difficult to envisage why this mutation was not shared by the JH3b-II segment.
In three of the B cell lymphomas studied, we observed alternative processing of IgH mRNA using a previously described cryptic splice donor site present in the FR1 of VH4 genes. 38, 39 In two of these cases, ie the somatically mutated B-CLL and FL13, we observed an identical mode of internal splicing of the V4-34 gene transcripts involving a so far unidentified cryptic 3Ј splice acceptor site ( Figures 3 and 4, Table 1 ). Moreover, by transfection studies in combination with the sitedirected mutagenesis, it was established that in the B-CLL this cryptic splice acceptor site had been activated due to a specific nucleotide substitution in codon 64 (CTC AAG → CTC CAG) ( Figure 6 ). Strikingly, FL13 carried a nucleotide substitution in codon 64 as well (CTC AAG → CTC AGG) although at a different position (Figure 3) . In both cases, however, a CAG sequence was generated which apparently was sufficient for the creation of a functional 3Ј splice acceptor site. This cryptic 3Ј splice acceptor site in V4-34 consists of a 26 bp stretch of which at least 18 bp are identical to consensus branchpoint and 3Ј splice acceptor sequences (Figures 3 and  7) . In DLBCL4, aberrant in-frame IgH transcripts were found in which the cryptic 5Ј splice donor site had been directly spliced to the CH1-C exon. This mode of IgH mRNA processing has been documented before in two Burkitt's lymphoma cell lines and leads to production of truncated, so-called heavy chain disease (HCD) proteins, which are secreted without associated IgL chain. 38, 39 In these cases, alternative splicing rescued the cells harboring non-functional V H genes with stop codons and/or frameshifts due to deletions or insertions. As we found high intraclonal variation in the V H gene of DLBCL4 it can be conceived that a fraction of the tumor cells contain disabled V H genes due to nonsense mutations and/or deletions/insertions and that those subclones use alternative V H splicing to survive. We can, however, not discriminate whether alternative splice forms are indeed produced by a subfraction of tumor cells or whether all tumor cells produce both normally and aberrantly spliced transcripts. In ␥-and ␣-HCD, which is associated with a variety of B cell malignancies, IgH splicing is even more extensive and usually involves part or all of the V H region and the whole CH1 domain. In most of these cases, the V H leader, with or without a small part of the V H region, is directly spliced to the hinge region. 41 The V4-34 gene segment has been found in virtually all cases of 'cold' agglutinin disease in which the autoantibodies have specificity for the i/I antigen present on erythrocytes. 42, 43 It is presently unclear whether the mutated V4-34 IgM/D expressed by our B-CLL has any causative role in the accompanying severe auto-immune hemolytic anemia (AIHA). In general, AIHA observed in B-CLL is considered to be caused by polyclonal, 'warm' reactive IgG antibodies unrelated to antibodies expressed by the tumor cells. 44, 45 Of all germline V H gene segments, codons 25-28 of FR1 of V4-34 have the highest homology to the consensus 5Ј splice site sequence (Figure 7 ). This may imply that V4-34-expressing B cells are more likely to produce HCD-like proteins, as we also detected in DLBCL4 on the transcriptional level. If true, this may be of relevance for the reported, overrepresentation of V4-34 usage in IgM +
CD5
+ B-CLL 19 and in primary central nervous large B cell lymphoma. 46 However, an initially reported bias of V4-34 in DLBCL 47 could not be reproduced in larger series. 37 The internal IgV H splicing observed in this B-CLL and in FL13, which to our knowledge has not been observed before, may have significance as an additional mechanism of somatic Ig diversification and underscores the flexibility of the system. It can be reasoned that in a IgV H gene with an intrinsic insertion or duplication, internal splicing may be a mechanism to compensate for non-functional frameshifts or length aberrations. This is also suggested by the increased ratio of spliced: unspliced IgV H in the 2J transfectant as compared to the 1J transfectant (Figure 6c ). On the other hand, alternative splicing implies that a B cell can potentially co-express different IgV H molecules encoded by one rearranged allele. Although it is doubtful whether this has any significance for normal B cell development, it is of note that HCD transcripts have been detected in bone marrow of normal humans. 48 This, combined with the finding that precursor B cells in HCDtransgenic mice were found to differentiate into mature B cells, 49, 50 may indicate that alternative IgV H splicing plays a role in rescuing B cells with non-functional rearrangements by allowing for additional gene recombination processes. Conversely, if such alternatively spliced IgV H gene products form aberrant protein complexes with ligand-independent signaling properties, like some HCD proteins, 49, 50 they could be instrumental in cellular transformation.
Leukemia
